Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

As the capabilities of generative AI models have grown, you've probably seen how they can transform simple text prompts into ...

The latest health news includes Robert F. Kennedy Jr.'s nomination, Abbott's strategy amid global challenges, and Purdue Pharma's opioid settlement. It highlights company strategies, profits, and ...

SEOUL, Jan. 24 (Korea Bizwire) — The South Korean government has announced an ambitious initiative to position the country as ...

I n today's rapidly advancing technological landscape, digital transformation is a key driver of innovation across many ...

Top advisers to Robert F. Kennedy Jr. are battling over how aggressively to target vaccines during his first days as the ...

Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships ...

Authenticated data presented in the Respiratory Drugs market report is based on findings of extensive primary and secondary research ...

The Deluge’ is a realist novel,” says author Stephen Markley of his 2023 epic. “It was about what we are going to live ...

Which Market Leaders Have Staked a Claim in the Brineura Market? The brineura market is served by several key industry players, with major companies including BioMarin Pharmaceutical Inc. leading the ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.